Mostrar el registro sencillo del ítem

dc.contributor.authorCordero, Alberto
dc.contributor.authorCid Álvarez, Belén
dc.contributor.authorAlegría Barrero, Eduardo 
dc.contributor.authorFernández Cisnal, Agustín
dc.contributor.authorEscribano, David
dc.contributor.authorBautista, Jennifer
dc.contributor.authorJuskova, María
dc.contributor.authorTrillo, Ramiro
dc.contributor.authorZuazola, Pilar
dc.contributor.authorFerreiro, José Luis
dc.date.accessioned2021-10-07T10:48:17Z
dc.date.available2021-10-07T10:48:17Z
dc.date.issued2021
dc.identifier.issn1522-1946spa
dc.identifier.urihttp://hdl.handle.net/10641/2480
dc.description.abstractBackground Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI) but it is performed in many procedures. The objective of our study was validating the DDTA score, designed for selecting patients who benefit most from MT. Methods Observational and multicenter study of all consecutive patients undergoing P-PCI in five institutions. Results were compared with the design cohort and the performance of the DDTA was analyzed in all patients. Primary end-point of the analyses was TIMI 3 after MT; secondary endpoints were final TIMI 3, no-reflow incidence, in-hospital mortality and in-hospital major cardiovascular events (MACE). In-hospital prognosis was assessed by the Zwolle risk score. Results Three hundred forty patients were included in the validation cohort and no differences were observed as compared to the design cohort (618 patients) except for lower use of MT and higher IIb/IIIa inhibitors or drug-eluting stents. The probability of TIMI 3 after MT decreased as delay to P-PCI was higher. If DDTA score, MT was associated to TIMI 3 after MT (OR: 4.11) and final TIMI 3 (OR: 2.44). There was a linear and continuous relationship between DDTA score and all endpoints. DDTA score ≥ 4 was independently associated to lower no-reflow, in-hospital MACE or mortality. The lowest incidence of in-hospital mortality or MACE was in patients who had DDTA score ≥ 4 and Zwolle risk score 0–3. Conclusions MT is associated to higher rate of final TIMI3 in patients with the DDTA score ≥ 4. Patients with DDTA score ≥ 4 had lower no-reflow and in-hospital complications.spa
dc.language.isoengspa
dc.publisherCatheterization and Cardiovascular Interventionsspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectThrombectomyspa
dc.subjectPrimary angioplastyspa
dc.titleMulticenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.spa
dc.typejournal articlespa
dc.type.hasVersionSMURspa
dc.rights.accessRightsopen accessspa
dc.description.extent1231 KBspa
dc.identifier.doi10.1002/ccd.29689spa
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.29689spa


Ficheros en el ítem

FicherosTamañoFormatoVer
1.- Multicenter and all-comers ...1.202MbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España